ReviewDiagnostics (Basel, Switzerland)2026
Chronic Occupational Stress and Immune-Inflammatory Dysregulation: Mechanisms, Clinical Consequences, Biomarkers and Implications for Occupational Medicine.
Review in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic occupational stress is associated with adverse cardiovascular, metabolic, and mental-health outcomes, but the biological evidence linking workplace exposures to immune-inflammatory dysregulation varies in directness and clinical relevance. This narrative review distinguishes findings demonstrated directly in occupational populations from mechanisms extrapolated from general psychological-stress, experimental, and preclinical models, and evaluates the potential utility of candidate biomarkers in occupational health. Prospective occupational evidence supports a weak and heterogeneous association between adverse psychosocial working conditions and inflammatory activity, with the clearest signal reported for IL-6. Mechanistic studies implicate hypothalamic-pituitary-adrenal axis dysregulation, altered sympathetic signaling, reduced glucocorticoid sensitivity, NF-κB-related transcription, cytokine responses, immune-cell alterations, oxidative stress, and stress-responsive gene regulation; however, much of this evidence derives from non-occupational models and primarily supports biological plausibility. Occupational epidemiological evidence is strongest for cardiovascular and selected metabolic outcomes, while associations with depressive symptoms and psychological distress are recurrent but remain limited by concerns regarding causal inference. Evidence linking occupational stress specifically to autoimmune and skeletal outcomes remains comparatively indirect. C-reactive protein, IL-6, salivary cortisol, and hair cortisol remain research-oriented measures because none has demonstrated sufficient occupational-stress specificity, validated diagnostic accuracy, clinically actionable thresholds, or incremental predictive value beyond established psychosocial and clinical assessment. Routine biomarker-based diagnosis or surveillance is therefore not currently supported. Future research should prioritize repeated assessment of occupational exposures and biomarkers, temporally appropriate mediation analyses, independent replication, and external validation before biological monitoring can inform routine occupational-health practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.